Stocklytics Platform
Asset logo for symbol ENTA
Enanta Pharmaceuticals
Asset logo for symbol ENTA



Income Statement (ENTA)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
gross Profit$16.43M$17.36M$18.26M$18.24M$17.25M
NET Income-$31.15M-$33.40M-$28.10M-$39.06M-$37.65M
total Revenue$17.05M$18.00M$18.93M$18.89M$17.79M

Balance Sheet (ENTA)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
cash Equivalents-----
net Debt$166.32M-$14.44M-$58.87M-$67.47M-$45.18M
stockholders Equity$166.11M$191.88M$216.73M$237.81M$269.37M
total Assets$413.55M$428.49M$462.27M$495.16M$326.44M
total Debt$229.86M$25.49M$26.51M$27.70M$27.99M
total Liabilities$247.44M$236.61M$245.54M$257.35M$57.07M

Cash Flow (ENTA)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
financing Cash Flow-$6.41M-$7.35M-$23.00K$199.87M-$2.02M
free Cash Flow-$30.26M-$25.77M-$22.97M-$34.27M-$16.16M
investing Cash Flow----$145.74M$46.76M
operating Cash Flow-$28.60M-$24.98M-$21.60M-$32.12M-$13.78M

Enanta Pharmaceuticals (ENTA) Financials

The income statement of Enanta Pharmaceuticals Inc (ENTA) provides a detailed breakdown of the company's financial performance. It shows the revenue generated by the company, as well as the costs and expenses incurred to generate that revenue. The EBIT (earnings before interest and taxes) is a measure of the company's operating profitability. It represents the earnings generated by the company before deducting interest and taxes. The EBITDA (earnings before interest, taxes, depreciation, and amortization) is a measure of the company's operating cash flow. It provides a more comprehensive view of the company's profitability by excluding non-cash expenses such as depreciation and amortization. The gross profit is the revenue remaining after deducting the cost of goods sold. It represents the profit generated directly from the production and sale of goods. The net income from stockholders is the profit or loss attributable to the company's stockholders. It represents the company's bottom line after all expenses and taxes have been accounted for. The total revenue is the sum of all revenues generated by the company. It includes both operating and non-operating revenues. The balance sheet of Enanta Pharmaceuticals Inc (ENTA) provides a snapshot of the company's financial condition. It shows the company's assets, liabilities, and stockholders' equity. The cash equivalents represent highly liquid assets that can be readily converted into cash. They include cash, bank deposits, and short-term investments. The net debt is the difference between the company's total debt and its cash and cash equivalents. It represents the company's debt after subtracting its readily available cash. The stockholders' equity is the residual interest in the assets of the company after deducting its liabilities. It represents the shareholders' ownership in the company. The total assets are the resources owned by the company. They include both tangible and intangible assets. The total debt is the sum of the company's short-term and long-term debt. It represents the company's obligations to pay back borrowed funds. The total liabilities are the company's obligations to third parties. They include both short-term and long-term liabilities. The cash flow statement of Enanta Pharmaceuticals Inc (ENTA) provides information about the company's cash inflows and outflows. It shows how the company generates and uses its cash. The financing cash flow represents the cash flows from financing activities, such as issuing or repurchasing stock and paying dividends. The free cash flow represents the amount of cash generated by the company that is available for distribution to investors, debt repayment, or investments. The investing cash flow represents the cash flows from investing activities, such as purchasing or selling assets. The operating cash flow represents the cash flows from operating activities, such as the company's day-to-day business operations.

add Enanta Pharmaceuticals  to watchlist

Keep an eye on Enanta Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.


Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level